entertainment -WSS

entertainment

author：comprehensive 2025-08-12 09:10:22 - browse：236

After physically debilitating cancer treatment, Laurie Brunner encountered another medical hurdle: She had developed lymphedema that required surgery, but her BMI was over the cutoff. To receive the necessary treatment, she would have to lose weight.

“But after everything I’ve been through, my body was just not having it,” she said. So she turned to Jody Dushay, an endocrinologist at the Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School. After much discussion, the two decided that Laurie should try using weight loss medication — specifically, Wegovy — so she could become eligible for the surgery.

Before long, they had to grapple with the shortage of GLP-1 medications. “Within the first two months she had a good response,” Jody said. But “then there was the first round of shortages. … It looks like, you know, we’re heading towards that finish line. And then, ‘Oh, sorry, you can’t get it anymore.’”

On the “First Opinion Podcast,” I spoke with Jody and Laurie about how the ongoing shortages of GLP-1 medications are creating logistical and medical problems. Our conversation was based on Jody’s recent First Opinion essay, “How the Wegovy shortage is making life impossible for my patients — and for me.” We talked about the patient and provider perspective, the way stigma affects access to care, the ways weight loss medications are changing the medical system, and how the drug shortage is only part of the problem of access.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Telehealth options flood the market as retailers push virtual care

explore

WSS

Readout Newsletter: XBI biotech index, Akero Therapeutics

7 people shot in DC, police say

Connecting traumatic brain injury and domestic violence

The FDA weighs the risks of candy

Paying for Covid pills will soon shift to insurers

Listen: PBM conflicts, RSV vaccines, & the future of flu season

focus

entertainment

hotspot

Continuity nursing helped my family in our darkest PICU moments

Grail is spending more than ever lobbying Congress

What does generative AI mean for health care? We asked experts

Pfizer's Covid pill remains 89% effective in final analysis, company says

Tori Bowie and the unacceptable rates of Black maternal death

Inside the fall of star MIT scientist David Sabatini

ChatGPT in medicine: STAT answers readers' burning questions

CDC recommends rationing of RSV shot due to shortages

Heart attack and stroke risk calculators need revising

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

knowledge

7 people shot in DC, police say

Community addresses injustice for Long Island mothers

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

PhRMA sues HHS over Medicare drug price negotiation

Traditional Chinese medicine benefits explored in new JAMA study

Senate panel to vote on hospitals, PBMs, prisoner care

focus

explore

knowledge

explore